🔗 Share this article

A shadow economy for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Treatment Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to individuals injecting substances of uncertain source.

Some professionals said the demand for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Elimination

Based on TikTok, the service has removed problematic material and prohibited related hashtags and query recommendations. The company said it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also discovered communities with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, positive testimonials and step-by-step guides for preparing or injecting at residence.

Within moments of entering one group, a vendor posted contact information, where most purchases occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.

Item Information and Costs

Inside these communities, posts display black plastic parcels with Royal Mail labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they can’t verify. Although the science behind this drug is sound, these online products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, patients are using social media. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously seen patients injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to possibly significant health risks”.